Search research articles
Contact Us
Filters
Showing results (361-370 of 456) with videos related to
Page
of 46
Sort By:
Plos One
|
January 23, 2026
Pharmacokinetics of Dolutegravir, nucleoside analogues, and intracellular metabolites using plasma separation cards: A comparative analysis with traditional sampling methods in healthy volunteers
Beth Thompson, Laura J Else, Laura Dickinson, et al.
Journal of Endodontics
|
July 27, 2025
Bacterial viability in persistent apical inflammatory lesions: A systematic review
D Nascimento, I C Guedes, L M Brand, et al.
Npj Imaging
|
June 13, 2025
Multimodal whole slide image processing pipeline for quantitative mapping of tissue architecture and tissue microenvironment
Maomao Chen, Hongqiang Ma, Xuejiao Sun, et al.
Small Methods
|
June 17, 2026
A Versatile Multiplexed Immunofluorescence Strategy for Efficient, Host-Independent, and Scalable Spatial Protein Profiling
Phuong Nguyen, Hongqiang Ma, Dimitrios S Gotsis, et al.
The Journal of Investigative Dermatology
|
October 31, 2016
A Topical Mitochondria-Targeted Redox-Cycling Nitroxide Mitigates Oxidative Stress-Induced Skin Damage
Rhonda M Brand, Michael W Epperly, J Mark Stottlemyer, et al.
Journal of Microscopy
|
September 17, 2009
Focused ion beam-scanning electron microscope: exploring large volumes of atherosclerotic tissue
L H P Hekking, M N Lebbink, D A M De Winter, et al.
Agents and Actions
|
November 1, 1990
Anti-inflammatory pharmacology and mechanism of the orally active capsaicin analogs, NE-19550 and NE-28345
L M Brand, K L Skare, M E Loomans, et al.
Molecular Cancer Therapeutics
|
April 3, 2019
Correction: Nuclear Epidermal Growth Factor Receptor Is a Functional Molecular Target in Triple-negative Breast Cancer
Toni M Brand, Mari Iida, Emily F Dunn, et al.
Molecular Cancer Therapeutics
|
March 18, 2014
Nuclear epidermal growth factor receptor is a functional molecular target in triple-negative breast cancer
Toni M Brand, Mari Iida, Emily F Dunn, et al.
Cancer Research
|
August 20, 2014
AXL mediates resistance to cetuximab therapy
Toni M Brand, Mari Iida, Andrew P Stein, et al.
Page
of 46
Search research articles
Search
Showing results (361-370 of 456) with videos related to
Sort By:
Page
of 46
Plos One
|
January 23, 2026
Pharmacokinetics of Dolutegravir, nucleoside analogues, and intracellular metabolites using plasma separation cards: A comparative analysis with traditional sampling methods in healthy volunteers
Beth Thompson, Laura J Else, Laura Dickinson, et al.
Journal of Endodontics
|
July 27, 2025
Bacterial viability in persistent apical inflammatory lesions: A systematic review
D Nascimento, I C Guedes, L M Brand, et al.
Npj Imaging
|
June 13, 2025
Multimodal whole slide image processing pipeline for quantitative mapping of tissue architecture and tissue microenvironment
Maomao Chen, Hongqiang Ma, Xuejiao Sun, et al.
Small Methods
|
June 17, 2026
A Versatile Multiplexed Immunofluorescence Strategy for Efficient, Host-Independent, and Scalable Spatial Protein Profiling
Phuong Nguyen, Hongqiang Ma, Dimitrios S Gotsis, et al.
The Journal of Investigative Dermatology
|
October 31, 2016
A Topical Mitochondria-Targeted Redox-Cycling Nitroxide Mitigates Oxidative Stress-Induced Skin Damage
Rhonda M Brand, Michael W Epperly, J Mark Stottlemyer, et al.
Journal of Microscopy
|
September 17, 2009
Focused ion beam-scanning electron microscope: exploring large volumes of atherosclerotic tissue
L H P Hekking, M N Lebbink, D A M De Winter, et al.
Agents and Actions
|
November 1, 1990
Anti-inflammatory pharmacology and mechanism of the orally active capsaicin analogs, NE-19550 and NE-28345
L M Brand, K L Skare, M E Loomans, et al.
Molecular Cancer Therapeutics
|
April 3, 2019
Correction: Nuclear Epidermal Growth Factor Receptor Is a Functional Molecular Target in Triple-negative Breast Cancer
Toni M Brand, Mari Iida, Emily F Dunn, et al.
Molecular Cancer Therapeutics
|
March 18, 2014
Nuclear epidermal growth factor receptor is a functional molecular target in triple-negative breast cancer
Toni M Brand, Mari Iida, Emily F Dunn, et al.
Cancer Research
|
August 20, 2014
AXL mediates resistance to cetuximab therapy
Toni M Brand, Mari Iida, Andrew P Stein, et al.
Page
of 46